Skip to content

Viatris VTRS Stock-Based Comp

Stock-Based Comp at other companies

Pfizer logo
PfizerPFE
$272M+60.0%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$10.19M+14.9%
Cencora logo
CencoraCOR
$28M-1.6%
AMP
Amphastar PharmaceuticalsAMPH
$9.27M+10.5%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$2.32M+46.1%
ARS Pharmaceuticals, Inc. logo
ARS Pharmaceuticals, Inc.SPRY
$7.42M+40.1%

Other financials

Income statement

See full
Revenue$3.5B+8.1%
Gross profit$1.2B-0.3%
Operating income-$79.7M+97.2%
Net income$176.4M+106%
EPS (diluted)$0.15+106%

Balance sheet

See full
Cash & equivalents$1.8B+139%
Total debt$14.6B+1.0%
Total equity$14.7B-6.3%
Total assets$36.8B-4.3%

Cash flow

See full
Operating cash flow$388.3M-27.5%
CapEx$39.9M-6.3%
Free cash flow$348.4M-29.3%

Valuation

See full
Market cap$20.8B+92.8%
Enterprise value$33.61B+34.5%
P/S1.4×+0.7×

Profitability

See full
Gross margin34.4%-2.5pp
Operating margin1%
Net margin-2%-1.0pp
FCF margin12.3%-1.0pp

Returns & leverage

See full
Return on equity-2%-0.9pp
Debt / equity+0.1×
Current ratio1.6×-0.1×

Where this comes from

Reported directly by Viatris in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Viatris’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viatris's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viatris's stock-based comp?
Viatris (VTRS) reported stock-based comp of $48.2M in Q1 2026.
How has Viatris's stock-based comp changed year-over-year?
Viatris's stock-based comp decreased by 12.7% year-over-year, from $55.2M to $48.2M.
What is the long-term trend for Viatris's stock-based comp?
Over 4 years (2021 to 2025), Viatris's stock-based comp has grown at a 12.4% compound annual growth rate (CAGR), from $111.2M to $177.7M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.